BioCryst Pharmaceuticals, Inc. - Common Stock (NQ: BCRX )

7.570 +0.180 (+2.44%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 20, 2024 Add to My Watchlist

Other Filings

Form 425
Source: SEC/Edgar
January 21, 2018
Form 425
Source: SEC/Edgar
January 21, 2018
Form 8-K
Source: SEC/Edgar
January 04, 2018
Form EFFECT
Source: SEC/Edgar
December 11, 2017
Form S-3/A
Source: SEC/Edgar
December 03, 2017
Form 424B5
Source: SEC/Edgar
September 10, 2017
Form 8-K
Source: SEC/Edgar
September 04, 2017
Form 8-K
Source: SEC/Edgar
August 06, 2017
Form 8-K
Source: SEC/Edgar
August 01, 2017
Form 8-K
Source: SEC/Edgar
April 11, 2017
Form DEFA14A
Source: SEC/Edgar
April 11, 2017
Form DEF 14A
Source: SEC/Edgar
April 11, 2017
Form 8-K
Source: SEC/Edgar
March 16, 2017
Form 8-K
Source: SEC/Edgar
March 14, 2017
Form 424B2
Source: SEC/Edgar
March 09, 2017
Form 424B5
Source: SEC/Edgar
March 07, 2017
Form SC 13G
Source: SEC/Edgar
March 05, 2017
Form CT ORDER
Source: SEC/Edgar
March 02, 2017
Form 8-K
Source: SEC/Edgar
February 26, 2017
Form 8-K
Source: SEC/Edgar
February 26, 2017
Form SC 13G/A
Source: SEC/Edgar
February 14, 2017
Form SC 13G/A
Source: SEC/Edgar
February 13, 2017
Form SC 13G/A
Source: SEC/Edgar
February 13, 2017
Form 8-K
Source: SEC/Edgar
January 29, 2017
Form SC 13G/A
Source: SEC/Edgar
January 18, 2017
Form 8-K
Source: SEC/Edgar
January 08, 2017
Form SC 13G
Source: SEC/Edgar
January 08, 2017
Form CT ORDER
Source: SEC/Edgar
December 27, 2016
Form 8-K
Source: SEC/Edgar
November 06, 2016
Form 8-K
Source: SEC/Edgar
October 25, 2016
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.